×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OLMA – olema pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OLMA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/13
08:56 pm
olma
JPM26: Roche's rejuvenation strategy for the oncology and haematology portfolio [Yahoo! Finance]
Medium
Report
JPM26: Roche's rejuvenation strategy for the oncology and haematology portfolio [Yahoo! Finance]
1/9
11:46 am
olma
Olema Insider Sells $8 Million in Shares After 300% Stock Surge [Yahoo! Finance]
Medium
Report
Olema Insider Sells $8 Million in Shares After 300% Stock Surge [Yahoo! Finance]
1/9
06:10 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/8
09:47 pm
olma
How Bullish Analyst Coverage and New Capital Raise Could Impact Olema Pharmaceuticals (OLMA) Investors [Yahoo! Finance]
Medium
Report
How Bullish Analyst Coverage and New Capital Raise Could Impact Olema Pharmaceuticals (OLMA) Investors [Yahoo! Finance]
1/7
10:11 am
olma
The banker, the brothers, the friends and their frauds [Investment Executive - News]
Medium
Report
The banker, the brothers, the friends and their frauds [Investment Executive - News]
1/7
08:02 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
1/7
02:01 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
1/5
04:30 pm
olma
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
07:00 am
olma
olema pharmaceuticals, inc.
MISS
Report
6.1%
olema pharmaceuticals, inc.
8/11/2025
04:01 pm
olma
olema pharmaceuticals, inc.
MISS
Report
8.5%
olema pharmaceuticals, inc.
5/13/2025
04:01 pm
olma
olema pharmaceuticals, inc.
BEAT
Report
-3.8%
olema pharmaceuticals, inc.
3/18/2025
04:01 pm
olma
olema pharmaceuticals, inc.
BEAT
Report
-0.7%
olema pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/15
09:00 pm
olma
Form 4 Olema Pharmaceuticals, For: Jan 13 Filed by: Kovacs Shane William Charles
Neutral
Report
Form 4 Olema Pharmaceuticals, For: Jan 13 Filed by: Kovacs Shane William Charles
1/15
04:23 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Low
Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
1/14
09:30 pm
olma
Form 4 Olema Pharmaceuticals, For: Jan 12 Filed by: Myles David C.
Low
Report
Form 4 Olema Pharmaceuticals, For: Jan 12 Filed by: Myles David C.
1/14
04:20 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Harmon Cyrus
Low
Report
Form 144 Olema Pharmaceuticals, Filed by: Harmon Cyrus
1/14
04:13 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Myles David C.
Low
Report
Form 144 Olema Pharmaceuticals, Filed by: Myles David C.
1/13
04:50 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Medium
Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
1/13
04:12 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Myles David C.
Medium
Report
Form 144 Olema Pharmaceuticals, Filed by: Myles David C.
1/12
04:45 pm
olma
Form 8-K Olema Pharmaceuticals, For: Jan 12
Medium
Report
Form 8-K Olema Pharmaceuticals, For: Jan 12
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: